P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED

• Eduard van Beers,
• Hanny Al-Samkari,
• Rachael F. Grace,
• Wilma Barcellini,
• Andreas Glenthøj,
• Vanessa Beynon,
• Megan Wind-Rotolo,
• Rengyi Xu,
• Melissa Dibacco,
• Parija Patel,
• John B. Porter,
• Kevin H.M. Kuo

Affiliations

Eduard van Beers

1 University Medical Center Utrecht, Utrecht University, Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, Utrecht, The Netherlands

Hanny Al-Samkari

2 Massachusetts General Hospital, Harvard Medical School, Division of Hematology, Boston, United States

Rachael F. Grace

3 Harvard Medical School, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, United States

Wilma Barcellini

4 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Andreas Glenthøj

5 Copenhagen University Hospital - Rigshospitalet, Danish Red Blood Cell Center, Department of Hematology, Copenhagen, Denmark

Vanessa Beynon

6 Agios Pharmaceuticals, Inc., Cambridge, United States

Megan Wind-Rotolo

6 Agios Pharmaceuticals, Inc., Cambridge, United States

Rengyi Xu

6 Agios Pharmaceuticals, Inc., Cambridge, United States

Melissa Dibacco

6 Agios Pharmaceuticals, Inc., Cambridge, United States

Parija Patel

6 Agios Pharmaceuticals, Inc., Cambridge, United States

John B. Porter

7 University College London Hospitals, Haematology Department, London, United Kingdom

Kevin H.M. Kuo

8 University of Toronto, Division of Hematology, Toronto, Canada